Member of the Association of American Physicians
Internal medicine, Primary sclerosing cholangitis, Gastroenterology, Cholangiocyte and Cell biology are his primary areas of study. The concepts of his Internal medicine study are interwoven with issues in Endocrinology and Surgery. His research in Primary sclerosing cholangitis intersects with topics in Primary biliary cirrhosis, Liver transplantation, Liver biopsy and Ulcerative colitis.
His Gastroenterology research is multidisciplinary, relying on both Cholangiography and Inflammatory bowel disease. His research integrates issues of Cell culture, Senescence, Biochemistry and Downregulation and upregulation in his study of Cholangiocyte. The various areas that Nicholas F. LaRusso examines in his Cell biology study include Receptor, Epithelium and Immune system.
His scientific interests lie mostly in Internal medicine, Cell biology, Gastroenterology, Primary sclerosing cholangitis and Cholangiocyte. His research on Internal medicine frequently links to adjacent areas such as Endocrinology. His work deals with themes such as Cryptosporidium parvum and Biochemistry, which intersect with Cell biology.
His work carried out in the field of Gastroenterology brings together such families of science as Surgery and Inflammatory bowel disease. He combines subjects such as Primary biliary cirrhosis, Liver transplantation, Liver biopsy and Ulcerative colitis with his study of Primary sclerosing cholangitis. His Cholangiocyte study incorporates themes from Receptor, Bile duct, Cell culture and Immunology.
Nicholas F. LaRusso mostly deals with Internal medicine, Primary sclerosing cholangitis, Gastroenterology, Cell biology and Cholangiocyte. Internal medicine is closely attributed to Endocrinology in his research. Primary sclerosing cholangitis is a primary field of his research addressed under Pathology.
His Alkaline phosphatase research extends to Gastroenterology, which is thematically connected. His studies in Cell biology integrate themes in fields like Microvesicles and Cell growth. The study incorporates disciplines such as Tumor necrosis factor alpha, Cancer research, Senescence, Fibrosis and MAPK/ERK pathway in addition to Cholangiocyte.
Nicholas F. LaRusso spends much of his time researching Cell biology, Cholangiocyte, Primary sclerosing cholangitis, Internal medicine and Immunology. The Cell biology study combines topics in areas such as Microvesicles and Biliary tract. His Cholangiocyte study combines topics in areas such as Fibrosis, Intrahepatic bile ducts and Bile acid.
His Primary sclerosing cholangitis research is under the purview of Pathology. His Internal medicine research includes elements of Gastroenterology and Endocrinology. He has researched Immunology in several fields, including Liver disease, Cell, Apoptosis and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif.
Autophagy (2021)
The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
Yi-Yi Zhu;Tamara Tchkonia;Tamar Pirtskhalava;Adam C Gower.
Aging Cell (2015)
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Russell H. Wiesner;Patricia M. Grambsch;E. Rolland Dickson;Jurgen Ludwig.
Hepatology (1989)
Clinicopathologic features of the syndrome of primary sclerosing cholangitis
Russell H. Wiesner;Nicholas F. LaRusso.
Gastroenterology (1980)
Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism.
Meeta Jaiswal;Nicholas F. LaRusso;Lawrence J. Burgart;Gregory J. Gores.
Cancer Research (2000)
Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.
C Penna;R Dozois;W Tremaine;W Sandborn.
Gut (1996)
Cholangiocarcinoma complicating primary sclerosing cholangitis.
Charles B. Rosen;David M. Nagorney;Russell H. Wiesner;Robert J. Coffey.
Annals of Surgery (1991)
Current concepts. Primary sclerosing cholangitis.
LaRusso Nf;Wiesner Rh;Ludwig J;MacCarty Rl.
The New England Journal of Medicine (1984)
A Cellular Micro-RNA, let-7i, Regulates Toll-like Receptor 4 Expression and Contributes to Cholangiocyte Immune Responses against Cryptosporidium parvum Infection
Xian Ming Chen;Patrick L. Splinter;Steven P. O'Hara;Nicholas F. LaRusso.
Journal of Biological Chemistry (2007)
The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis
Anand H Patel;Denise M Harnois;George G Klee;Nicholas F LaRusso.
The American Journal of Gastroenterology (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Mayo Clinic
Arizona State University
Creighton University
Mayo Clinic
University of California, San Diego
Mayo Clinic
University Health Network
KU Leuven
University of Barcelona
Boston University
Rutgers, The State University of New Jersey
Tsinghua University
University of Washington
Dalian University of Technology
Ulsan National Institute of Science and Technology
National Institutes of Health
University of California, San Francisco
The Hertz Corporation
Inserm : Institut national de la santé et de la recherche médicale
Hebrew University of Jerusalem
Florida State University
Cardiff University
Mayo Clinic
Auburn University
London School of Economics and Political Science